{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:25:32Z","timestamp":1792275932609,"version":"4.4.0"},"reference-count":172,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1590\/abd1806-4841.20153638","type":"journal-article","created":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T22:23:19Z","timestamp":1446934999000},"page":"687-706","source":"Crossref","is-referenced-by-count":68,"title":["Cutaneous primary B-cell lymphomas: from diagnosis to treatment"],"prefix":"10.1590","volume":"90","author":[{"given":"Margarida","family":"Lima","sequence":"first","affiliation":[{"name":"Hospital de Santo Ant\u00f3nio, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/(SICI)1097-0215(19970917)72:6<923::AID-IJC1>3.0.CO;2-R","article-title":"The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extra-nodal sites","volume":"72","author":"Newton R","year":"1997","journal-title":"Int J Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford PT","year":"2009","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/107327481201900308","article-title":"Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management","volume":"19","author":"Sokol L","year":"2012","journal-title":"Cancer Control"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1309\/AJCPNLC9NC9WTQYY","article-title":"Cutaneous B-cell lymphoproliferative disorders: report of the 2011 Society for Hematopathology\/European Association for Haematopathology workshop","volume":"139","author":"Swerdlow SH","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ajh.23360","article-title":"Cutaneous B-cell lymphomas: 2013 update on diagnosis, risk-stratification, and management","volume":"88","author":"Wilcox RA","year":"2013","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/DAD.0b013e318289b20e","article-title":"Cutaneous lymphomas: an update. Part 2: B-cell lymphomas and related conditions","volume":"36","author":"Kempf W","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jaad.2013.06.011","article-title":"Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification","volume":"69","author":"Su\u00e1rez AL","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"ref8","author":"Su\u00e1rez AL"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.0303-6987.2005.00495.x","article-title":"WHO\/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects","volume":"32","author":"Burg G","year":"2005","journal-title":"J Cutan Pathol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze R","year":"2005","journal-title":"Blood"},{"key":"ref11","series-title":"WHO Classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow SH","year":"2008"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2008-09-180315","article-title":"HIV-associated lymphomas and gamma-herpesviruses","volume":"113","author":"Carbone A","year":"2009","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1034\/j.1600-0560.2003.00083.x","article-title":"Hepatitis C and G viruses in B-cell lymphomas of the skin","volume":"30","author":"Michaelis S","year":"2003","journal-title":"J Cutan Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-4362.2002.01603.x","article-title":"B-cell lymphomas involving the skin associated with hepatitis C virus infection","volume":"41","author":"Viguier M","year":"2002","journal-title":"Int J Dermatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0190-9622(91)70088-J","article-title":"Borrelia burgdorferi-associated cutaneous B-cell lymphoma: clinical and immunohistologic characterization of four cases","volume":"24","author":"Garbe C","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000106580","article-title":"Borrelia burgdorferi-associated primary cutaneous marginal-zone B-cell lymphoma: a case report","volume":"215","author":"Monari P","year":"2007","journal-title":"Dermatology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2141.2005.05904.x","article-title":"Analysis of immunoglobulin V genes suggests cutaneous marginal zone B-cell lymphomas recognise similar antigens","volume":"132","author":"Bahler DW","year":"2006","journal-title":"Br J Haematol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.0303-6987.2003.00167.x","article-title":"Borrelia burgdorferiassociated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases","volume":"31","author":"Colli C","year":"2004","journal-title":"J Cutan Pathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/modpathol.2008.159","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States","volume":"21","author":"Takino H","year":"2008","journal-title":"Mod Pathol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1080\/10428190701618250","article-title":"Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association","volume":"48","author":"Goteri G","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1634\/theoncologist.2011-0108","article-title":"Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas","volume":"16","author":"Ponzoni M","year":"2011","journal-title":"Oncologist"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1365-2133.1996.tb03621.x","article-title":"Reversible cutaneous lymphoma occurring during methotrexate therapy","volume":"135","author":"Viraben R","year":"1996","journal-title":"Br J Dermatol"},{"key":"ref23","first-page":"1546","article-title":"Primary cutaneous B-cell lymphoma during methotrexate therapy for rheumatoid arthritis","volume":"27","author":"Fam AG","year":"2000","journal-title":"J Rheumatol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0025-6196(11)63231-X","article-title":"Cutaneous lymphoma associated with Epstein-Barr virus infection in 2 patients treated with methotrexate","volume":"76","author":"Tournadre A","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e717","DOI":"10.1200\/JCO.2010.28.3796","article-title":"Primary cutaneous Epstein-Barr virus-associated B-cell lymphoma arising at the site of subcutaneous injections of methotrexate","volume":"28","author":"Giard C","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref26","first-page":"282","article-title":"Patterns of cutaneous lymphomas. Histological, enzyme cytochemical, and immunological typing of lymphoreticular proliferations in the skin","volume":"157","author":"Burg G","year":"1978","journal-title":"Dermatologica"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1600-0560.2012.01975.x","article-title":"Flow cytometry of lesional skin enhances the evaluation of cutaneous B-cell lymphomas","volume":"39","author":"Wu JM","year":"2012","journal-title":"J Cutan Pathol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/modpathol.2008.30","article-title":"Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma","volume":"21","author":"Xie X","year":"2008","journal-title":"Mod Pathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00000372-200608000-00001","article-title":"Cytogenetic and molecular analysis of 12 cases of primary cutaneous marginal zone lymphomas","volume":"28","author":"de la Fouchardiere A","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1182\/blood-2005-08-3443","article-title":"Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID","volume":"107","author":"Dijkman R","year":"2006","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00428-008-0593-x","article-title":"Inactivation of p16INK4a\/CDKN2A gene may be a diagnostic feature of large B-cell lymphoma leg type among cutaneous B-cell lymphomas","volume":"452","author":"Belaud-Rotureau MA","year":"2008","journal-title":"Virchows Arch"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1600-0625.2010.01226.x","article-title":"Simultaneous aberrations of single CDKN2A network components and a high Rb phosphorylation status can differentiate subgroups of primary cutaneous B-cell lymphomas","volume":"20","author":"Kaune KM","year":"2011","journal-title":"Exp Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1523-1747.2003.12142.x","article-title":"Gene expression profiles of cutaneous B-cell lymphoma","volume":"120","author":"Storz MN","year":"2003","journal-title":"J Invest Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel JJ","year":"2005","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/1097-0142(19900515)65:10<2301::AID-CNCR2820651023>3.0.CO;2-M","article-title":"Differentiation between lymphadenosis benigna cutis and primary cutaneous follicular center cell lymphomas. A comparative clinicopathologic study of 57 patients","volume":"65","author":"Rijlaarsdam JU","year":"1990","journal-title":"Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0733-8635(18)30188-8","article-title":"Semimalignant (\"pseudolymphomatous\") cutaneous B-cell lymphomas","volume":"12","author":"Burg G","year":"1994","journal-title":"Dermatol Clin"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00000372-200004000-00009","article-title":"Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas","volume":"22","author":"Schaerer L","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/DAD.0000000000000022","article-title":"Clonality Assessment of Cutaneous B-Cell Lymphoid Proliferations: A Comparison of Flow Cytometry Immunophenotyping, Molecular Studies, and Immunohistochemistry\/In Situ Hybridization and Review of the Literature","volume":"36","author":"Schafernak KT","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/10428190802064925","article-title":"Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL\/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome","volume":"49","author":"Golling P","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff NJ","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.pas.0000146015.22624.c7","article-title":"Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas","volume":"29","author":"Kim BK","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"ref42","first-page":"435","article-title":"Skin manifestation of mantle cell lymphoma","volume":"16","author":"Motegi S","year":"2006","journal-title":"Eur J Dermatol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jaad.2008.12.047","article-title":"Unusual cutaneous manifestations of B-cell chronic lymphocytic leukemia","volume":"60","author":"Plaza JA","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1600-0560.2009.01402.x","article-title":"Subclinical chronic lymphocytic leukemia with atypical cutaneous presentation","volume":"38","author":"Ali L","year":"2011","journal-title":"J Cutan Pathol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.leukres.2013.08.009","article-title":"Extramedullary chronic lymphocytic leukemia: systematic analysis of cases reported between 1975 and 2012","volume":"38","author":"Ratterman M","year":"2014","journal-title":"Leuk Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12185-011-0794-y","article-title":"M protein deposition in the skin: a rare manifestation of Waldenstr\u00f6m macroglobulinemia","volume":"93","author":"Oberschmid B","year":"2011","journal-title":"Int J Hematol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/cup.12151","article-title":"Cutaneous macroglobulinosis with monotypic plasma cells: a specific manifestation of Waldenstr\u00f6m macroglobulinemia","volume":"40","author":"Spicknall KE","year":"2013","journal-title":"J Cutan Pathol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/DAD.0b013e3182726e79","article-title":"Cutaneous nodules as a diagnostic clue in multiple myeloma","volume":"35","author":"Ballester-Mart\u00ednez MA","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/archderm.1990.01670280093017","article-title":"Pathogenesis of paraneoplastic follicular hyperkeratotic spicules in multiple myeloma. Follicular and epidermal accumulation of IgG dysprotein and cryoglobulin","volume":"126","author":"Bork K","year":"1990","journal-title":"Arch Dermatol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0190-9622(95)91542-7","article-title":"Follicular spicules of the nose: a peculiar cutaneous manifestation of multiple myeloma with cryoglobulinemia","volume":"32","author":"Requena L","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000063918","article-title":"Multiple hyperkeratotic spicules and myeloma","volume":"205","author":"Braun RP","year":"2002","journal-title":"Dermatology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/PPO.0b013e31826c5e19","article-title":"Lymphomatoid granulomatosis","volume":"18","author":"Roschewski M","year":"2012","journal-title":"Cancer J"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jaad.2006.02.030","article-title":"Cutaneous involvement by Burkitt lymphoma","volume":"54","author":"Jacobson MA","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff NJ","year":"2008","journal-title":"Blood"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00000478-199608000-00010","article-title":"Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients","volume":"20","author":"Bailey EM","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00000478-199711000-00005","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma","volume":"21","author":"Cerroni L","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1085-5629(00)80009-7","article-title":"The skin-associated lymphoid tissue-related B-cell lymphomas","volume":"19","author":"Pimpinelli N","year":"2000","journal-title":"Semin Cutan Med Surg"},{"key":"ref58","series-title":"World Health Organization Classification of Tumours Pathology and Genetics of Skin Tumors","first-page":"194","volume-title":"Cutaneous marginal zone B-cell lymphoma","author":"Kempf W","year":"2006"},{"key":"ref59","series-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"214","volume-title":"Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)","author":"Isaacson PG","year":"2008","edition":"4th ed"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.critrevonc.2009.09.003","article-title":"Primary cutaneous marginal zone lymphoma","volume":"74","author":"Dalle S","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000372-200104000-00007","article-title":"Anetoderma arising in cutaneous B-cell lymphoproliferative disease","volume":"23","author":"Kasper RC","year":"2001","journal-title":"Am J Dermatopathol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"e945","DOI":"10.1111\/j.1365-2230.2009.03593.x","article-title":"Anetoderma in cutaneous marginal-zone B-cell lymphoma","volume":"34","author":"Zattra E","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archdermatol.2009.340","article-title":"Anetodermic primary cutaneous B-cell lymphoma: a unique clinicopathological presentation of lymphoma possibly associated with antiphospholipid antibodies","volume":"146","author":"Hodak E","year":"2010","journal-title":"Arch Dermatol"},{"key":"ref64","first-page":"342","article-title":"Primary cutaneous marginal zone B-cell lymphoma with anetoderma: spontaneous involution plus de novo clonal expansion","volume":"38","author":"Ferrara G","year":"2011","journal-title":"J Cutan Pathol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00000372-200006000-00001","article-title":"Extranodal marginal zone B-cell lymphoma of the skin: a morphologic and immunophenotypic study of 11 cases","volume":"22","author":"Tomaszewski MM","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/modpathol.2008.159","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States","volume":"21","author":"Takino H","year":"2008","journal-title":"Mod Pathol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/PAS.0b013e3181a6ae1e","article-title":"CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and pathogenetic implications","volume":"33","author":"Kutzner H","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1046\/j.0022-202x.2001.01482.x","article-title":"Molecular analysis of the immunoglobulin heavy chain gene in the diagnosis of primary cutaneous B-cell lymphoma","volume":"117","author":"Child FJ","year":"2001","journal-title":"J Invest Dermatol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1182\/blood-2002-09-2963","article-title":"T(14;18) (q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma","volume":"101","author":"Streubel B","year":"2003","journal-title":"Blood"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.leu.2403644","article-title":"T(3;14)(p14.11;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma","volume":"19","author":"Streubel B","year":"2005","journal-title":"Leukemia"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/path.1711","article-title":"FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma","volume":"205","author":"Schreuder MI","year":"2005","journal-title":"J Pathol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.humpath.2006.02.012","article-title":"Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma","volume":"37","author":"Gallardo F","year":"2006","journal-title":"Hum Pathol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets","volume":"34","author":"Edinger JT","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"ref74","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze R","year":"1997","journal-title":"Blood"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0190-9622(88)70169-3","article-title":"Reticulohistiocytoma of the dorsum","volume":"19","author":"Berti E","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood.V95.12.3922","article-title":"Primary cutaneous follicle center cell lymphoma with follicular growth pattern","volume":"95","author":"Cerroni L","year":"2000","journal-title":"Blood"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1200\/JCO.2002.20.3.647","article-title":"Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features","volume":"20","author":"Mirza I","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2005-03-1175","article-title":"Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients","volume":"106","author":"Kodama K","year":"2005","journal-title":"Blood"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archderm.143.9.1144","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases","volume":"143","author":"Grange F","year":"2007","journal-title":"Arch Dermatol"},{"key":"ref80","first-page":"589","article-title":"Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment","volume":"147","author":"Paulli M","year":"2012","journal-title":"G Ital Dermatol Venereol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2133.2000.03471.x","article-title":"Primary cutaneous B-cell lymphoma: a clinical, histological, phenotypic and genotypic study of 21 cases","volume":"142","author":"Gr\u00f8nbaek K","year":"2000","journal-title":"Br J Dermatol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1200\/JCO.2005.02.0842","article-title":"Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma","volume":"24","author":"Dijkman R","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/00000372-199512000-00017","article-title":"Primary cutaneous T-cell-rich B-cell lymphoma. A case report with a 13-year follow-up","volume":"17","author":"Dommann SN","year":"1995","journal-title":"Am J Dermatopathol"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00000372-199506000-00005","article-title":"Malignant angioendotheliomatosis is an angiotropic intravascular lymphoma. Immunohistochemical, ultrastructural, and molecular genetics studies","volume":"17","author":"Perniciaro C","year":"1995","journal-title":"Am J Dermatopathol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","article-title":"Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the \"cutaneous variant Br","volume":"127","author":"Ferreri AJ","year":"2004","journal-title":"J Haematol"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/00000478-199707000-00016","article-title":"Intravascular large cell lymphoma coexisting within hemangiomas of the skin","volume":"21","author":"Rubin MA","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1365-2133.2000.03608.x","article-title":"Angiotropic lymphoma: proliferation of B-cells in the capillaries of cutaneous angiomas","volume":"143","author":"Kobayashi T","year":"2000","journal-title":"Br J Dermatol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1368-8375(01)00018-5","article-title":"Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations","volume":"38","author":"Flaitz CM","year":"2002","journal-title":"Oral Oncol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1100\/tsw.2011.59","article-title":"Plasmablastic lymphoma: a systematic review","volume":"11","author":"Castillo JJ","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1309\/AJCPV1I2QWKZKNJH","article-title":"Plasmablastic lymphoma and related disorders","volume":"136","author":"Hsi ED","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/10428194.2011.608447","article-title":"Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge","volume":"53","author":"Montes-Moreno S","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities","volume":"28","author":"Colomo L","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":"Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles","volume":"18","author":"Vega F","year":"2005","journal-title":"Mod Pathol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000077324","article-title":"Cutaneous plasmablastic lymphoma in an HIV-positive male: an unrecognized cutaneous manifestation","volume":"208","author":"H\u00e4usermann P","year":"2004","journal-title":"Dermatology"},{"key":"ref95","first-page":"45","article-title":"Plasmablastic lymphoma in a patient with HIV infection: an unusual case located in the skin","volume":"25","author":"Dales JP","year":"2005","journal-title":"Ann Pathol"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2559.2005.01985.x","article-title":"Plasmablastic lymphoma arising at a cutaneous site","volume":"46","author":"Jordan LB","year":"2005","journal-title":"Histopathology"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0560.2006.00539.x","article-title":"KSHV\/ HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma","volume":"33","author":"Liu W","year":"2006","journal-title":"J Cutan Pathol"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaad.2007.08.009","article-title":"Cutaneous plasmablastic lymphoma","volume":"58","author":"Jambusaria A","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1468-3083.2007.02342.x","article-title":"Cutaneous nodules as diagnostic key of an extraoral plasmablastic lymphoma in an human immunodeficiency virus-infected patient","volume":"22","author":"Bernabeu-Wittel J","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref100","first-page":"862585","article-title":"A Case of Cutaneous Plasmablastic Lymphoma in HIV\/ AIDS with Disseminated Cryptococcus","volume":"2013","author":"Gong J","year":"2013","journal-title":"Case Rep Oncol Med"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.0303-6987.2005.00258.x","article-title":"Epstein-Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation","volume":"32","author":"Verma S","year":"2005","journal-title":"J Cutan Pathol"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1016\/j.jaad.2012.02.021","article-title":"Primary cutaneous plasmablastic lymphoma of the lower leg in an HIV-negative patient","volume":"67","author":"Heiser D","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1016\/j.jaad.2013.06.050","article-title":"Primary cutaneous plasmablastic lymphoma in an immunocompetent patient","volume":"69","author":"Horna P","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"ref104","first-page":"541783","article-title":"Cutaneous plasmablastic lymphoma in an immunocompetent patient with long-term pyrimethamine use for essential thrombocythemia: a case report and literature review","volume":"2013","author":"Tiong IS","year":"2013","journal-title":"Case Rep Hematol"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1016\/j.jaad.2013.07.003","article-title":"Cutaneous plasmablastic lymphoma in a nonimmunocompromised patient","volume":"69","author":"Eke U","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"ref106","first-page":"177","article-title":"Primary cutaneous T-cell-rich B-cell lymphoma: a case report and literature review","volume":"17","author":"Venizelos ID","year":"2008","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000327376","article-title":"Cutaneous T-cell\/histiocyte-rich B-cell lymphoma: a case report and review of the literature","volume":"222","author":"Vezzoli P","year":"2011","journal-title":"Dermatology"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.pai.0000143347.58174.91","article-title":"Primary cutaneous CD30+ large cell B-cell lymphoma: a series of 10 cases","volume":"14","author":"Magro CM","year":"2006","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen E","year":"2007","journal-title":"Blood"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","article-title":"TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Kim YH","year":"2007","journal-title":"Blood"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani PL","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2013.07.019","article-title":"Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience","volume":"87","author":"Hamilton SN","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0190-9622(97)80405-7","article-title":"Borrelia burgdorferiassociated primary cutaneous B-cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a","volume":"36","author":"K\u00fctting B","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"ref114","series-title":"Modern Dermatologic Radiation Therapy","first-page":"123","volume-title":"Radiation therapy of other cutaneous tumors","author":"Goldschmidt H","year":"1991"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0733-8635(05)70013-9","article-title":"Radiotherapy in the treatment of dermatologic malignancies","volume":"16","author":"Voss N","year":"1998","journal-title":"Dermatol Clin"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0167-8140(99)00089-4","article-title":"Radiotherapy in the management of cutaneous B-cell lymphoma. Our experience in 25 cases","volume":"52","author":"Kirova YM","year":"1999","journal-title":"Radiother Oncol"},{"key":"ref117","first-page":"49","article-title":"Dermatologic radiotherapy of primary cutaneous follicle center cell lymphoma","volume":"13","author":"Piccinno R","year":"2003","journal-title":"Eur J Dermatol"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2004.08.044","article-title":"Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems","volume":"22","author":"Smith BD","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2133.2010.09798.x","article-title":"Intralesional corticosteroid therapy for primary cutaneous B-cell lymphoma","volume":"163","author":"Perry A","year":"2010","journal-title":"Br J Dermatol"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archderm.136.3.374","article-title":"Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma","volume":"136","author":"Heinzerling L","year":"2000","journal-title":"Arch Dermatol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1046\/j.1365-2133.2001.04241.x","article-title":"Intralesional rituximab for cutaneous B-cell lymphoma","volume":"144","author":"Paul T","year":"2001","journal-title":"Br J Dermatol"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-0609.2006.00720.x","article-title":"Favorable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab","volume":"77","author":"Kyrtsonis MC","year":"2006","journal-title":"Eur J Haematol"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0001-7310(08)74678-7","article-title":"Cutaneous follicular center B-cell lymphoma treated with intralesional rituximab","volume":"99","author":"Gamo R","year":"2008","journal-title":"Actas Dermosifiliogr"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2133.2012.10902.x","article-title":"Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma","volume":"167","author":"Pe\u00f1ate Y","year":"2012","journal-title":"Br J Dermatol"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2133.2000.03607.x","article-title":"Rituximab in cutaneous B-cell lymphoma: a report of two cases","volume":"143","author":"Sabroe RA","year":"2000","journal-title":"Br J Dermatol"},{"key":"ref126","first-page":"205","article-title":"Anti-CD20 antibodies in primary cutaneous B-cell lymphoma. Initial results in dermatologic patients","volume":"52","author":"Gellrich S","year":"2001","journal-title":"Hautarzt"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2133.2005.06659.x","article-title":"Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas-an applicational observation","volume":"153","author":"Gellrich S","year":"2005","journal-title":"Br J Dermatol"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1080\/10428190600688099","article-title":"Cutaneous B-cell lymphoma responds to rituximab: a report of five cases and a review of the literature","volume":"47","author":"Gitelson E","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jaad.2008.08.005","article-title":"Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab","volume":"59","author":"Morales AV","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/annonc\/mdn636","article-title":"Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients","volume":"20","author":"Valencak J","year":"2009","journal-title":"Ann Oncol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/bjd.12484","article-title":"Long-term outcome of intravenous therapy with rituximab in patients with primary cutaneous B-cell lymphomas","volume":"169","author":"Brandenburg A","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref132","first-page":"315","article-title":"Complete remission following recombinant interferon alpha-2a in a patient with diffuse large B-cell cutaneous lymphoma","volume":"31","author":"Tourani JM","year":"1989","journal-title":"Nouv Rev Fr Hematol"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0190-9622(97)80405-7","article-title":"Borrelia burgdorferiassociated primary cutaneous B-cell lymphoma: complete clearing of skin lesions after antibiotic pulse therapy or intralesional injection of interferon alfa-2a","volume":"36","author":"K\u00fctting B","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s004320050144","article-title":"Complete response of a primary cutaneous T-cell-rich B-cell lymphoma treated with interferon alpha2a","volume":"124","author":"Wollina U","year":"1998","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s004320050278","article-title":"Primary cutaneous marginal center lymphoma - complete remission induced by interferon alpha2a","volume":"125","author":"Wollina U","year":"1999","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/10428190500399698","article-title":"Intralesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma","volume":"47","author":"Cozzio A","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-0609.2008.01197.x","article-title":"Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies","volume":"82","author":"Pulini S","year":"2009","journal-title":"Eur J Haematol"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/ejh.12315","article-title":"Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas","volume":"93","author":"Fabbri A","year":"2014","journal-title":"Eur J Haematol"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1200\/JCO.2001.19.2.398","article-title":"Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy","volume":"19","author":"Sarris AH","year":"2001","journal-title":"J Clin Oncol"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jamadermatol.2013.7452","article-title":"Improvement of Survival in Patients With Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, in France","volume":"150","author":"Grange F","year":"2014","journal-title":"JAMA Dermatol"},{"key":"ref141","first-page":"753","article-title":"Rituximab for primary cutaneous diffuse large B-cell lymphoma-leg type","volume":"20","author":"Fenot M","year":"2010","journal-title":"Eur J Dermatol"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archdermatol.2009.345","article-title":"Combined treatment with rituximab and anthracycline-containing chemotherapy for primary cutaneous large B-cell lymphomas, leg type, in elderly patients","volume":"146","author":"Guyot A","year":"2010","journal-title":"Arch Dermatol"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1200\/JCO.1999.17.8.2471","article-title":"Treatment of multifocal primary cutaneous B-cell lymphoma: a clinical follow-up study of 29 patients","volume":"17","author":"Bekkenk MW","year":"1999","journal-title":"J Clin Oncol"},{"key":"ref144","first-page":"366","article-title":"Therapy of cutaneous lymphoma-current practice and future developments","volume":"26","author":"Dummer R","year":"2003","journal-title":"Onkologie"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.0303-6987.2006.00544.x","article-title":"Standard and new treatments in cutaneous B-cell lymphomas","volume":"33","author":"Dreno B","year":"2006","journal-title":"J Cutan Pathol"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0360-3016(02)04199-8","article-title":"Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma","volume":"55","author":"Eich HT","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref147","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1067\/mjd.2003.154","article-title":"Cutaneous marginal zone B-cell lymphoma: a case accompanied by massive plasmacytoid cells","volume":"48","author":"Kiyohara T","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ajh.20019","article-title":"Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients","volume":"75","author":"Sah A","year":"2004","journal-title":"Am J Hematol"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","article-title":"Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification","volume":"143","author":"Senff NJ","year":"2007","journal-title":"Arch Dermatol"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1440-0960.2003.00655.x","article-title":"Clinical study of primary cutaneous B-cell lymphoma using both the European Organization for Research and Treatment of Cancer and World Health Organization classifications","volume":"44","author":"Yap LM","year":"2003","journal-title":"Australas J Dermatol"},{"key":"ref151","first-page":"438","article-title":"Rituximab in the Treatment of Primary Cutaneous B-Cell Lymphoma: A Review","volume":"105","author":"Fern\u00e1ndez-Guarino M","year":"2014","journal-title":"Actas Dermosifiliogr"},{"key":"ref152","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1440-0960.2004.00027.x","article-title":"Treatment of primary cutaneous follicular centre lymphoma with rituximab: a report of two cases","volume":"45","author":"Kennedy GA","year":"2004","journal-title":"Australas J Dermatol"},{"key":"ref153","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jaad.2005.01.093","article-title":"Treatment of primary cutaneous B-cell lymphoma with rituximab","volume":"52","author":"Fink-Puches R","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"ref154","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2230.2004.01659.x","article-title":"Treatment of radiationrelapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody","volume":"30","author":"Lacouture ME","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"ref155","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/annonc\/mdl113","article-title":"Rituximab-related urticarial reaction in a patient treated for primary cutaneous B-cell lymphoma","volume":"17","author":"Errante D","year":"2006","journal-title":"Ann Oncol"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1365-2133.2006.07523.x","article-title":"Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases","volume":"155","author":"Kerl K","year":"2006","journal-title":"Br J Dermatol"},{"key":"ref157","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1016\/j.leukres.2010.02.013","article-title":"Eightcycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma","volume":"34","author":"Seker M","year":"2010","journal-title":"Leuk Res"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000332074","article-title":"Focal rituximab-induced edematous reaction at primary cutaneous follicle center lymphoma lesions: case report and literature review","volume":"223","author":"Brunet-Possenti F","year":"2011","journal-title":"Dermatology"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2340\/00015555-1113","article-title":"Systemic rituximab in multifocal primary cutaneous follicle centre lymphoma","volume":"91","author":"Qu\u00e9reux G","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"ref160","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1182\/blood.V94.7.2217.419k02_2217_2224","article-title":"Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8)","volume":"94","author":"Winkler U","year":"1999","journal-title":"Blood"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1365-2141.2001.03166.x","article-title":"Complement activation plays a key role in the side-effects of rituximab treatment","volume":"115","author":"van der Kolk LE","year":"2001","journal-title":"Br J Haematol"},{"key":"ref162","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/annonc\/mdf350","article-title":"Stevens-Johnson syndrome after treatment with rituximab","volume":"13","author":"Lowndes S","year":"2002","journal-title":"Ann Oncol"},{"key":"ref163","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/annonc\/mdg488","article-title":"Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment","volume":"14","author":"Hellerstedt B","year":"2003","journal-title":"Ann Oncol"},{"key":"ref164","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D34NS1K655","article-title":"A review of rituximab in cutaneous medicine","volume":"12","author":"Scheinfeld N","year":"2006","journal-title":"Dermatol Online J"},{"key":"ref165","first-page":"343","article-title":"Induction of apoptosis and inhibition of cell growth are independent responses to interferonalpha in hematopoietic cell lines","volume":"8","author":"Sangfelt O","year":"1997","journal-title":"Cell Growth Differ"},{"key":"ref166","doi-asserted-by":"crossref","first-page":"D479","DOI":"10.2741\/Sangfelt","article-title":"Mechanisms of interferon-induced cell cycle arrest","volume":"5","author":"Sangfelt O","year":"2000","journal-title":"Front Biosci"},{"key":"ref167","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.leukres.2009.10.024","article-title":"Red nose: primary cutaneous marginal zone B-cell lymphoma","volume":"34","author":"Rosmaninho A","year":"2010","journal-title":"Leuk Res"},{"key":"ref168","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4103\/0378-6323.86502","article-title":"Primary cutaneous follicle center lymphoma responsive to interferon alfa-2a","volume":"77","author":"Kavala M","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref169","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5070\/D36M138533","article-title":"Letter: Primary cutaneous marginal zone B-cell lymphoma of the face: a challenging diagnosis","volume":"18","author":"Oliveira A","year":"2012","journal-title":"Dermatol Online J"},{"key":"ref170","first-page":"566","article-title":"Skin problems associated with pegylated liposomal doxorubicin-more than palmoplantar erythrodysesthesia syndrome","volume":"18","author":"Mangana J","year":"2008","journal-title":"Eur J Dermatol"},{"key":"ref171","first-page":"264","article-title":"Skin problems associated with pegylated liposomal doxorubicin - more than palmoplantar erythrodysesthesia syndrome","volume":"19","author":"Von Moos R","year":"2009","journal-title":"Eur J Dermatol"},{"key":"ref172","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1610-0387.2010.07449.x","article-title":"The handfoot-syndrome associated with medical tumor therapy - classification and management","volume":"8","author":"Degen A","year":"2010","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v90n5\/0365-0596-abd-90-05-0687.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:43Z","timestamp":1747666843000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962015000500687&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":172,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0365-05962015000500687"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20153638","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}